Drapkina, O. M., & Vasilyeva, L. E. (2020). Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19. «SILICEA-POLIGRAF» LLC.
Chicago Style (17th ed.) CitationDrapkina, O. M., and L. E. Vasilyeva. Debatable Points of Using Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Patients with COVID-19. «SILICEA-POLIGRAF» LLC, 2020.
MLA (9th ed.) CitationDrapkina, O. M., and L. E. Vasilyeva. Debatable Points of Using Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Patients with COVID-19. «SILICEA-POLIGRAF» LLC, 2020.
Warning: These citations may not always be 100% accurate.